drugset / Trial / NCT00746824

A Study to Determine the Effects of TM30339 on Weight Loss in Obese Individuals.

NCT00746824 ↗

Phase 2 Terminated 192 enrolled 7TM Pharma A/S
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine the effects of TM30339 on weight loss in obese individuals after 28 days dosing.

Timeline

Start
2008-08
Primary completion
2009-01
Completion
2009-03

Outcome

Outcome not reported

Stopped: “The IND was withdrawn.”

Drugs

EvaluationDrugModalityDoseRoute
Subject TM30339 Unknown 0.85 mg Subcutaneous
Subject TM30339 Unknown 2.55 mg Subcutaneous

Indications